Clinical trial
A Prospective, Multicenter Clinical Trial in Evaluating the Safety and Efficacy of the Coronary Crossing System in Patients With Coronary Chronic Total Occlusions
NCT05813704 is registered in ClinicalTrials.gov with Shanghai MicroPort Rhythm MedTech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Clinical Trial in Evaluating the Safety and Efficacy of the Coronary Crossing System in Patients With Coronary Chronic Total Occlusions
- Lead sponsor
- Shanghai MicroPort Rhythm MedTech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 7, 2023
- Completion date
- August 19, 2024
- Enrollment
- 159 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic total occlusion of coronary artery